WTG
PPH icon

West Tower Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

West Tower Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-409
Closed -$33.3K – 415
2023
Q4 		$33.3K Sell
409
-17
-4% -$1.33K 0.07% 231
2023
Q3 		$34K Buy
+426
New +$34.4K 0.02% 263

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

West Tower Group's PPH Position: Q1 2024 in Review

West Tower Group sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2024, closing a stake of 409 shares — an estimated $33.3K sold.

West Tower Group first reported a position in PPH in Q3 2023 and held it in 2 quarters. The position peaked at $34K in Q3 2023. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

  • West Tower Group reported no remaining VanEck Pharmaceutical ETF position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 409 VanEck Pharmaceutical ETF shares in Q1 2024, an estimated $33.3K.
  • West Tower Group first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and held it in 2 quarters.
  • West Tower Group's VanEck Pharmaceutical ETF position peaked at $34K in Q3 2023.
  • 138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.